Related Experiment Videos
Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid
R M Lavker1, K Kaidbey, J J Leyden
1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 19104.
Background:
Topical corticosteroids produce atrophic changes in skin, including thinning of the epidermis and decrease in dermal ground substance. We observed that 12% ammonium lactate produced an increase in the thickness of epidermis and increased amounts of dermal glycosaminoglycans.
Objective:
Our purpose was to determine whether 12% ammonium lactate could minimize cutaneous atrophy produced by a potent topical corticosteroid.
Methods:
Clobetasol propionate, 12% ammonium lactate, and both agents were repetitively applied under occlusive patches as well as in open patches on the forearms of human volunteers for 3 to 4 weeks. Biopsy specimens were analyzed for thickness of the epidermis and dermal glycosaminoglycans by image analysis.
Results:
Twelve percent ammonium lactate produced a significant sparing of atrophy in both the epidermis and dermis without any influence on the bioavailability or antiinflammatory properties of the corticosteroid.
Conclusion:
Twelve percent ammonium lactate may be useful in mitigating the adverse effects of corticosteroid on skin.